The grey zone between pure (neuro)endocrine and non-(neuro)endocrine tumours: A comment on concepts and classification of mixed exocrine-endocrine neoplasms

Virchows Archiv

Volumn 449, Issue 5, 2006, Pages 499-506

  Volante, Marco ^a   Rindi, Guido ^b   Papotti, Mauro ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF PARMA   (Italy)

Author keywords

Adenocarcinoma; Diagnosis; Mixed endocrine exocrine carcinoma; Neuroendocrine differentiation

Indexed keywords

ADENOCARCINOMA; CANCER CLASSIFICATION; CARCINOID; HUMAN; IMMUNOPHENOTYPING; INTERNATIONAL CLASSIFICATION OF DISEASES; LUNG NON SMALL CELL CANCER; MIXED TUMOR; MUCINOUS CARCINOMA; NEUROENDOCRINE TUMOR; NOMENCLATURE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROSTATE ADENOCARCINOMA; REVIEW; WORLD HEALTH ORGANIZATION;

ADENOCARCINOMA; CELL DIFFERENTIATION; CHROMOGRANIN A; ENDOCRINE GLAND NEOPLASMS; HUMANS; NEUROENDOCRINE TUMORS; NEUROSECRETORY SYSTEMS;

EID: 33750883193     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00428-006-0306-2     Document Type: Review

References (59)

1. Abbona G, Papotti M, Viberti L, Macri L, Stella A, Bussolati G (1998) Chromogranin A gene expression in non-small cell lung carcinomas. J Pathol 186:151-156
2. Atasoy P, Ensari A, Demirci S, Kursun N (2003) Neuroendocrine differentiation in colorectal carcinomas: assessing its prognostic significance. Tumori 89:49-53
3. Berruti A, Mosca A, Tucci M, Terrone C, Torta M, Tarabuzzi R, Russo L, Cracco C, Bollito E, Scarpa RM, Angeli A, Dogliotti L (2005) Independent prognostic role of circulating chromogranin A in prostate cancer patients with hormone-refractory disease. Endocr Relate Cancer 12:107-115
4. Blumenfeld W, Chandhoke DK, Sagerman P, Turi GK (1996) Neuroendocrine differentiation in gastric adenocarcinomas. An immunohistochemical study. Arch Pathol Lab Med 120:478-481
5. Bollito E, Berruti A, Bellina M, Mosca A, Leonardo E, Tarabuzzi R, Cappia S, Ari MM, Tampellini M, Fontana D, Gubetta L, Angeli A, Dogliotti L (2001) Relationship between neuroendocrine features and prognostic parameters in human prostate adenocarcinoma. Ann Oncol 12S:159-164
6. Bollito ER, Pacchioni D, Lopez-Beltran A, Volante M, Terrone C, Casetta G, Mari M, DePompa R, Cappia S, Papotti M (2005) Immunohistochemical study of neuroendocrine differentiation in primary glandular lesions and tumours of the urinary bladder. Anal Quant Cytol Histol 27:218-224
7. Borges M, Linnoila RI, vandeVelde HJK, Chen H, Nelkin BD, Mabry M, Baylin SB, Ball DW (1997) An achaete-scute homologue essential for neuroendocrine differentiation in the lung. Nature 386:852-855
8. Brambilla E, Moro D, Veale D, Brichon PY, Stoebner P, Paramelle B, Brambilla C (1992) Basal cell (basaloid) carcinoma of the lung: a new morphologic and phenotypic entity with separate prognostic significance. Hum Pathol 23:993-1003
9. Brambilla E, Lantuejoul S, Sturm N (2000) Divergent differentiation in neuroendocrine lung tumors. Semin Diagn Pathol 17:138-148
10. Capella C, La Rosa S, Uccella S, Billo P, Cornaggia M (2000) Mixed endocrine-exocrine tumors of the gastrointestinal tract. Semin Diagn Pathol 17:91-103
11. Chejfec G, Capella C, Solcia E, Jao W, Gould VE (1985) Amphicrine cells, dysplasias, and neoplasias. Cancer 56:2683-2690
12. Crafa P, Milione M, Azzoni C, Pilato FP, Pizzi S, Bordi C (2003) Pleomorph poorly differentiated endocrine carcinoma of the rectum. Virchows Arch 442:605-610
13. DeLellis RA, Tischler AS, Wolfe HJ (1984) Multidirectional differentiation in neuroendocrine neoplasms. J Histochem Cytochem 32:899-904
14. DeLellis RA, LLoyd R, Heitz PU (eds) (2004) World Health Organization classification of tumors, pathology and genetics - tumors of endocrine organs. IARC, Lyon
15. Deshpande V, Selig MK, Nielsen GP, Fernandez-del Castillo C, Lauwers GY (2003) Ductulo-insular pancreatic endocrine neoplasms: clinicopathologic analysis of a unique subtype of pancreatic endocrine neoplasms. Am J Surg Pathol 27:461-468
16. Eble JN, Sauter G, Epstein JI, Sesterhenn IA (2004) World Health Organization classification of tumours, pathology and genetics - tumours of the urinary system and male genital organs. IARC, Lyon
17. Evans AJ, Al-Maghrabi J, Tsihlias J, Lajoie G, Sweet JM, Chapman WB (2002) Primary large cell neuroendocrine carcinoma of the urinary bladder. Arch Pathol Lab Med 126:1229-1232
18. Evans AJ, Humphrey PA, Belani J, van der Kwast TH, Srigley JR (2006) Large cell neuroendocrine carcinoma of prostate: a clinicopathologic summary of 7 cases of a rare manifestation of advanced prostate cancer. Am J Surg Pathol 30:684-693
19. Foley EF, Gaffey MJ, Frierson HF Jr (1998) The frequency and clinical significance of neuroendocrine cells within stage III adenocarcinomas of the colon. Arch Pathol Lab Med 122:912-914
20. Foschini MP, Eusebi V (2000) Divergent differentiation in endocrine and nonendocrine tumors of the skin. Semin Diagn Pathol 17:162-168
21. Gilks CB, Young RH, Gersell DJ, Clement PB (1997) Large cell neuroendocrine [corrected] carcinoma of the uterine cervix: a clinicopathologic study of 12 cases. Am J Surg Pathol 21:905-914
22. Grabowski P, Schindler I, Anagnostopoulos I, Foss HD, Riecken EO, Mansmann U, Stein H, Berger G, Buhr HJ, Scherubl H (2001) Neuroendocrine differentiation is a relevant prognostic factor in stage III-IV colorectal cancer. Eur J Gastroenterol Hepatol 13(4):405-411
23. Grabowski P, Schonfelder J, Ahnert-Hilger G, Foss HD, Heine B, Schindler I, Stein H, Berger G, Zeitz M, Scherubl H (2002) Expression of neuroendocrine markers: a signature of human undifferentiated carcinoma of the colon and rectum. Virchows Arch 441:256-263
24. Greene L, Brundage W, Cooper K (2005) Large cell neuroendocrine carcinoma of the larynx: a case report and a review of the classification of this neoplasm. J Clin Pathol 58:658-661
25. Hamilton SR, Aaltonen L (2000) World Health Organization Classification of tumors. Pathology and genetics-tumors of the digestive system. IARC, Lyon
26. Hamilton K, Chiappori A, Olson S, Sawyers J, Johnson D, Washington K (2000) Prevalence and prognostic significance of neuroendocrine cells in esophageal adenocarcinoma. Mod Pathol 13:475-481
27. Helpap B, Kloppel G (2002) Neuroendocrine carcinomas of the prostate and urinary bladder: a diagnostic and therapeutic challenge. Virchows Arch 440:241-248
28. Hong SM, Kim MJ, Pi DY, Jo D, Yu E, Ro JY (2005) Neuroendocrine differentiation in extrahepatic bile duct carcinomas and its prognostic significance. Hum Pathol 36:732-740
29. Howe MC, Chapman A, Kerr K, Dougal M, Anderson H, Hasleton PS (2005) Neuroendocrine differentiation in non-small cell lung cancer and its relation to prognosis and therapy. Histopathology 46:195-201
30. Indinnimeo M, Cicchini C, Memeo L, Stazi A, Provenza C, Ricci F, Mingazzini PL (2002) Correlation between chromogranin-A expression and pathological variables in human colon carcinoma. Anticancer Res 22:395-398
31. Ito T, Udaka N, Okudela K, Yazawa T, Kitamura H (2003) Mechanisms of neuroendocrine differentiation in pulmonary neuroendocrine cells and small cell carcinoma. Endocr Pathol 14:129-133
32. Jain D, Eslami-Varzaneh F, Takano A, Ayer U, Umashankar R, Muller R, Klimstra D (2005) Composite glandular and endocrine tumors of the stomach with pancreatic acinar differerentiation. Am J Surg Pathol 29:1524-1529
33. Kloppel G (2000) Mixed exocrine-endocrine tumors of the pancreas. Semin Diagn Pathol 17:104-108
34. Lewin K (1987) Carcinoid tumors and the mixed (composite) glandular-endocrine cell carcinomas. Am J Surg Pathol 11:71-76
35. Makretsov N, Gilks CB, Codman AJ, Hayes M, Huntsman D (2003) Tissue microarray analysis of neuroendocrine differentiation and its prognostic significance in breast cancer. Hum Pathol 34:1001-1008
36. Moukassa D, Leroy X, Bouchind'homme B, Saint F, Lemaitre L, Gosselin B (2000) Primary large cell neuroendocrine carcinoma of the kidney: morphologic and immunohistochemical features of two cases. Ann Pathol 20:357-360
37. Nagao T, Sugano I, Ishida Y, Tajima Y, Munakata S, Asoh A, Yamazaki K, Muto H, Konno A, Kondo Y, Nagao K (2000) Primary large-cell neuroendocrine carcinoma of the parotid gland: immunohistochemical and molecular analysis of two cases. Mod Pathol 13:554-561
38. Nassar H, Albores-Saavedra J, Klimstra DS (2005) High-grade neuroendocrine carcinoma of the ampulla of vater: a clinicopathologic and immunohistochemical analysis of 14 cases. Am J Surg Pathol 29:588-594
39. Oberg K, Kvols L, Caplin M, DelleFave G, DeHerder W, Rindi G, Ruszniewski P, Woltering EA, Wiedenmann B (2004) Consensus report on the use of somatostatin analogs for the management of neuroendocrine tumors of the gastroenteropancreatic system. Ann Oncol 15:966-973
40. Ohike N, Jurgensen A, Pipeleers-Marichal M, Kloppel G (2003) Mixed ductal-endocrine carcinomas of the pancreas and ductal adenocarcinomas with scattered endocrine cells: characterization of the endocrine cells. Virchows Arch 442:258-265
41. Ohike N, Kosmahl M, Kloppel G (2004) Mixed acinar-endocrine carcinoma of the pancreas. A clinicopathological study and comparison with acinar-cell carcinoma. Virchows Arch 445:231-235
42. Ooi A, Hayashi H, Katsuda S, Nakanishi I (1992) Gastric carcinoma cells with endocrine differentiation show no evidence of proliferation. Hum Pathol 23:736-741
43. Pagani A, Papotti M, Abbona GC, Bussolati G (1995) Chromogranin gene expression in colorectal adenocarcinomas. Mod Pathol 8:626-632
44. Papotti M, Galliano D, Monga G (1990) Signet ring cell carcinoid of the gallbladder. Histopathology 17:255-259
45. Papotti M, Cassoni P, Sapino A, Passarino G, Krueger JE, Albores-Saavedra J (2000) Large cell neuroendocrine carcinoma of the gallbladder: report of two cases. Am J Surg Pathol 24:1424-1428
46. Pelosi G, Pasini F, Sonzogni A, Maffini F, Maisonneuve P, Iannucci A, Terzi A, De Manzoni G, Bresaola E, Viale G (2003) Prognostic implications of neuroendocrine differentiation and hormone production in patients with Stage I non-small cell lung carcinoma. Cancer 97:2487-2497
47. Reis-Filho JS, Schmitt FC (2001) Amphicrine gastric carcinoma. Arch Pathol Lab Med 125:1513-1514
48. Rosen PP, Oberman HA (1992) Atlas of tumor pathology. Tumors of the mammary gland. AFIP, Washington, pp 157-243
49. Sapino A, Righi L, Cassoni P, Papotti M, Pietribiasi F, Bussolati G (2000) Expression of the neuroendocrine phenotype in carcinomas of the breast. Semin Diagn Pathol 17:127-137
50. Sapino A, Righi L, Cassoni P, Papotti M, Bussolati G (2001) Neuroendocrine differentiation in breast carcinoma. Mod Pathol 14:768-776
51. Shia J, Tickoo SK, Guillem JG, Qin J, Nissan A, Hoos A, Stojadinovic A, Ruo L, Wong WD, Paty PB, Weiser MR, Minsky BD, Klimstra DS (2002) Increased endocrine cells in treated rectal adenocarcinomas: a possible reflection of endocrine differentiation in tumor cells induced by chemotherapy and radiotherapy. Am J Surg Pathol 26:863-872
52. Slovin SF (2006) Neuroendocrine differentiation in prostate cancer: a sheep in wolf's clothing? Nat Clin Pract Urol 3:138-144
53. Solcia E, Kloppel G, Sobin LH (2000) World Health Organization International histological classification of tumors. Histological typing of endocrine tumors. Springer, Berlin Heidelberg New York, pp 56-68
54. Tavassoli FA, Devilee P (2003) World Health Organization classification of tumours, pathology and genetics - tumours of the breast. IARC, Lyon, pp 32-34
55. Travis WD, Linnoila RI, Tsokos MG, Hitchcock CL, Cutler GB Jr, Nieman L, Chrousos G, Pass H, Doppman J (1991) Neuroendocrine tumors of the lung with proposed criteria for large-cell neuroendocrine carcinoma. An ultrastructural, immunohistochemical, and flow cytometric study of 35 cases. Am J Surg Pathol 15:529-553
56. Travis WD, Brambilla E, Muller-Hermelink HK, Harris CC (2004) World Health Organization Classification of tumors, pathology and genetics - tumors of the lung, pleura, thymus and heart. IARC, Lyon, pp 19-20; 31-34
57. van Eeden S, de Leng WW, Offerhaus GJ, Morsink FH, Weterman MA, de Krijger RR, Kloppel G, Klimstra DS (2004) Ductuloinsular tumors of the pancreas: endocrine tumors with entrapped nonneoplastic ductules. Am J Surg Pathol 28:813-820
58. vanKrimpen C, Elferink A, Broodman CA, Hp WC, Pronk A, Menke M (2004) The prognostic influence of neuroendocrine differentiation in breast cancer: results of a long-term follow-up study. Breast 13:329-333
59. Volante M, Sapino A, Papotti M, Pacchioni D, Bussolati G (2004) Neuroendocrine differentiation patterns in various organs (including lung, breast, skin, and urogenital tract). In: Lloyd RV (ed) Endocrine pathology. Differential diagnosis and molecular advances. Humana, Totowa, USA, pp 345-358